Literature DB >> 13558750

Serum enzymes in disease. I. Lactic dehydrogenase and glutamic oxalacetic transaminase in carcinoma.

M WEST, H J ZIMMERMAN.   

Abstract

Entities:  

Keywords:  DEHYDROGENASES/in blood; NEOPLASMS/blood in; TRANSAMINASES/in blood

Mesh:

Substances:

Year:  1958        PMID: 13558750     DOI: 10.1001/archinte.1958.00260190105012

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN: 0888-2479


× No keyword cloud information.
  8 in total

1.  PRIMARY CARCINOMA OF THE LIVER; ANALYSIS OF CLINICAL AND BIOCHEMICAL FEATURES OF 80 CASES.

Authors:  D SANJOSE; A CADY; M WEST; B CHOMET; H J ZIMMERMAN
Journal:  Am J Dig Dis       Date:  1965-08

2.  [Enzymatic distribution patterns of the glycolytic system and citric acid cycle in the plasma of cancer patients].

Authors:  R MERTEN; H G SOLBACH
Journal:  Klin Wochenschr       Date:  1961-03-01

3.  Lactic dehydrogenase activity in acute myocardial infarction.

Authors:  J KING; A P WAIND
Journal:  Br Med J       Date:  1960-11-05

4.  Serum lactic dehydrogenase activity in hepatic disorders in infancy and childhood.

Authors:  I Chandra; S Inamdar; A T Dabke; M A Khan; P S Mathur
Journal:  Indian J Pediatr       Date:  1973-09       Impact factor: 1.967

5.  Serum enzyme changes after major lung surgery--with and without halothane.

Authors:  A R Hunter
Journal:  Thorax       Date:  1968-07       Impact factor: 9.139

6.  [Enzyme activity of LDH, MDH, ALD, GOT, and GPT in human serum and plasma and in erythrocytes in polycythemia vera].

Authors:  H Haug
Journal:  Klin Wochenschr       Date:  1966-06-15

7.  Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase.

Authors:  M H Gault; M W Cohen; L M Kahana; F T Leelin; J F Meakins; M Aronovitch
Journal:  Can Med Assoc J       Date:  1967-01-14       Impact factor: 8.262

8.  EFFECT OF NITROSAMINE DERIVATIVES ON ENZYME CONCENTRATIONS IN RAT ORGANS DURING CARCINOGENESIS.

Authors:  C HOCH-LIGETI; L T LOBL; J M ARVIN
Journal:  Br J Cancer       Date:  1964-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.